VC  De Novo Ventures

http://www.denovovc.com





     Office Locations:

PO Box 2160
Saratoga, CA 95070
Phone: 650-329-1999
Fax: 650-329-1315

 

Stages:

  • Early
  • Expansion
  • Growth
  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Founded March of 2000, De Novo Ventures is a healthcare investment firm. De Novo's principals have participated as both entrepreneurs and investors in the earliest stages of many product areas that now represent significant businesses within the health care sector of the global economy including angioplasty, minimally invasive cardiac surgery, endoscopy and spine therapy. Currently, De Novo has $650 million under management, and expects to invest $8-15 million over the life of a transaction. The De Novo team has made over 40 investments (across three funds) in both the biotechnology and medical device sectors. Denovo is investing its third firm, DNV III. The firm invests in all stages of enterprise development and growth - from early stage to late stage. Eight exits have occurred from the first fund; four were successful IPOs.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Frederick Dotzler Managing Director
    Joe Mandato Managing Director
    Richard Ferrari Managing Director

     

    Portfolio companies include:


      Articulinx
        web link


      Astute Medical
        web link


      Avedro
        web link


      Bayhill Therapeutics
        web link


      Benvenue
        web link


      C2 Therapeutics
        web link


      Cavu Medical
        web link


      EBR Systems
        web link


      Facet Solutions
        web link


      HemaQuest
        web link


      iScience Interventional
        web link


      Luminous Medical
        web link


      MyoScience
        web link


      Paracor Medical
        web link


      PhotoThera
        web link


      PulmonX
        web link


      Simpirica
        web link


      Spinal Kinetics
        web link


      Spiracur
        web link


      TearScience
        web link


      TRIA Beauty
        web link


      Ventus Medical
        web link


      WaveTec Vision
        web link


     

    Recent News: